Issue 34, 2021

Molecular diagnostics in the era of COVID-19

Abstract

As the COVID-19 pandemic continues to escalate globally and acquires new mutations, accurate diagnostic technologies continue to play a vital role in controlling and understanding the epidemiology of this disease. A plethora of technologies have enabled the diagnosis of individuals, informed clinical management, aided population-wide screening to determine transmission rates and identified cases within the wider community and high-risk settings. This review explores the application of molecular diagnostics technologies in controlling the spread of COVID-19, and the key factors that affect the sensitivity and specificity of the tests used.

Graphical abstract: Molecular diagnostics in the era of COVID-19

Article information

Article type
Critical Review
Submitted
03 6 2021
Accepted
05 8 2021
First published
05 8 2021
This article is Open Access
Creative Commons BY license

Anal. Methods, 2021,13, 3744-3763

Molecular diagnostics in the era of COVID-19

H. Jayakody, G. Kiddle, S. Perera, L. Tisi and H. S. Leese, Anal. Methods, 2021, 13, 3744 DOI: 10.1039/D1AY00947H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements